Modified GRF (1-29)
Modified GRF (1-29), also known as Mod GRF 1-29, is a synthetic peptide that is used in the field of pharmacology and biochemistry. It is a modified version of the shortest fully functional fragment of the Growth Hormone-Releasing Hormone (GHRH), which is responsible for the growth hormone release in the human body.
History
Modified GRF (1-29) was developed after the discovery of the naturally occurring hormone, GHRH. Scientists modified the structure of GHRH to create a synthetic peptide with improved stability and efficacy. The number 1-29 refers to the position of the amino acids in the peptide chain that are responsible for its biological activity.
Structure and Function
Modified GRF (1-29) is a 29 amino acid peptide, which is the same length as the active portion of GHRH. It has been modified to increase its stability and potency. The modifications include the substitution of the 2nd, 8th, 15th and 27th amino acids, and the addition of a terminal amide group.
The primary function of Modified GRF (1-29) is to stimulate the release of growth hormone from the pituitary gland. It does this by binding to the GHRH receptor on the pituitary cells, triggering a cascade of events that leads to the release of growth hormone.
Pharmacology
In pharmacological studies, Modified GRF (1-29) has been shown to have a potent effect on growth hormone release. It has a half-life of about 30 minutes, which is significantly longer than that of natural GHRH. This makes it a useful tool in research and potentially in the treatment of conditions related to growth hormone deficiency.
Potential Applications
While Modified GRF (1-29) is primarily used in research, it has potential applications in the treatment of conditions such as growth hormone deficiency, muscle wasting diseases, and certain forms of dwarfism. However, more research is needed to fully understand its effects and potential side effects.
See Also
This article is a biochemistry stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD